Advertisement

Topics

Selecta Biosciences, Inc. Company Profile

14:24 EST 13th February 2016 | BioPortfolio

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Selecta's proprietary Synthetic Vaccine Particle (SVP™) platform creates a new paradigm in vaccine development, enabling completely new therapeutic applications while offering the potential of improved efficacy and safety profiles. Selecta’s fully synthetic engineering of novel vaccines offers a number of compelling benefits, including flexible modular vaccine design and accelerated development timelines using robust manufacturing processes. Selecta’s SVP™ platform technology is flexible to enable diverse vaccines and the company has created targeted antigen-specific Synthetic Vaccine Particles (tSVP™) and targeted antigen-specific tolerogenic Synthetic Vaccine Particles (t2SVP™).


News Articles [500 Associated News Articles listed on BioPortfolio]

Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round

Crossover investors—institutions that back both public and private companies—have been piling money into biotechs over the past few years. Today you can add Selecta Biosciences to the list...

Selecta Biosciences, Inc. - Product Pipeline Review - 2015

Recently added to the BioPortfolio report store, Selecta Biosciences, Inc. - Product Pipeline Review - 2015 is a new report from Global Markets Direct published on 2015-08-30. This 31-page report is ...

Selecta raises $38M in series E

Selecta Biosciences Inc. (Watertown, Mass.) raised $38 million in a series E round led by existing investor OrbiMed. New investors Sanofi Genzyme Bioventures; Ridgeback Capital Management; Osage Partn...

Series E brings in $38mm for Selecta

Selecta Biosciences Inc. (antigen-specific immunotherapeutics) raised $38mm via its oversubscribed Series E financing to returning shareholders OrbiMed, Polaris Partners, Flagship Ventures, NanoDimens...

Selecta Biosciences Appoints Earl E. Sands, MD, as Chief Medical Officer

Selecta Biosciences, Inc., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune therapies using Synthetic Vaccine Particles (...

Selecta Announces $38 Million Series E Equity Financing

Proceeds from financing to enable advancement of multiple product pipeline of antigen-specific immunotherapies and vaccines Phase 2 study of lead immunotherapeutic candidate, SEL-212, in gout planne...

Selecta Announces $38 Million Series E Financing

Proceeds from financing to enable advancement of multiple product pipeline of antigen-specific immunotherapies and vaccines Phase 2 study of lead immunot...

Selecta completes venture financing

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Cell-mediated immunity (CMI) and in particular T cells play a critical role in the rejection of transplanted organs. Thus, in transplant recipients a life-long and individualized immunosup...

Companies [322 Associated Companies listed on BioPortfolio]

Selecta Biosciences, Inc.

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen...

Selecta Biosciences, Inc. and Genethon

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Valent BioSciences Corporation

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and co...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Selecta Biosciences, Inc." on BioPortfolio

We have published hundreds of Selecta Biosciences, Inc. news stories on BioPortfolio along with dozens of Selecta Biosciences, Inc. Clinical Trials and PubMed Articles about Selecta Biosciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Selecta Biosciences, Inc. Companies in our database. You can also find out about relevant Selecta Biosciences, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...


Corporate Database Quicklinks



Searches Linking to this Company Record